BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Debt-to-equity ratio
Latest
-4.01
↓ 42% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineCompressed
Average
-2.82
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -4.01 | -126.6% |
| 2024 | -1.77 | +2.4% |
| 2023 | -1.81 | +28.0% |
| 2022 | -2.52 | +54.6% |
| 2021 | -5.55 | +61.8% |
| 2020 | -14.51 | -755.7% |
| 2019 | 2.21 | +2720.2% |
| 2018 | -0.08 | +2.5% |
| 2017 | -0.09 | +8.7% |
| 2016 | -0.09 | - |